The World Health Organization has announced that it has cleared the emergency use of China’s Sinovac vaccine, which is still in use in Turkey.
While the WHO has approved the use of the Sinovac vaccine in adults over 18 years of age, it has determined an interval of 2 to 4 weeks for the second dose of the vaccine.
In the statement made by the WHO, it was stated that an upper age limit has not been determined for the Sinovac vaccine, because according to the available data, it has been proven that the vaccine also offers protection to patients. the elderly.
Thus, Sinovac became the second vaccine produced by China to be approved for immediate use.
With this approval, Sinovac is expected to be included in the international COVAX vaccination program established by the WHO for poor countries’ access to the vaccine.